State Medicaid programs must cover medication assisted treatment under a new mandatory benefit that takes effect today.

The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 added the benefit to increase access to evidenced-based treatment for opioid use disorder for Medicaid beneficiaries.

Specifically, states must cover all forms of drugs and biologicals that the Food and Drug Administration has approved or licensed for MAT to treat OUD, the Centers for Medicare & Medicaid Services said today in a . 

 

Related News Articles

Headline
The AHA April 30 released a report highlighting how hospitals and health systems continue to experience significant financial headwinds that can challenge…
News
The AHA April 29 urged majority and minority leaders in both the Senate and House to not make disruptive policy changes to Medicaid and other coverage options…
Headline
Twelve House Republicans April 14 sent a letter to House leadership voicing their opposition to potential Medicaid cuts. The lawmakers said they support “…
Headline
The AHA yesterday released two new resources highlighting the significance of Medicaid and the potential impacts if Congress makes cuts to the program. An…
Headline
The Centers for Medicare & Medicaid Services April 10 announced that it does not intend to approve new or extend existing requests for federal funds to…
Perspective
Public
Congressional lawmakers are heading home for a two-week district work period after both the Senate and House passed a revised budget resolution for fiscal year…